Virtual Biotech, a multi-agent AI drug discovery system, published in Science
james_y_zou · x · 2026-09-19
- A team published Virtual Biotech in Science: a multi-agent AI system modeled on a biotech company, where a virtual Chief Scientific Officer coordinates specialist AI scientists for therapeutic discovery; code is open source.
- Specialist agents analyze domain data while a scientific reviewer evaluates methods and claims, with traceable evidence throughout.
- A retrospective analysis of 55,984 clinical trials links target cell-type specificity to clinical progression and adverse-event rates; it also explores B7-H3 in lung cancer.
- Motivation: over 90% of trial-stage drugs fail; agents aim to integrate fragmented evidence across disciplines.
Related event: Stanford's Virtual Biotech: 37,000 AI Agents Land Science Cover(10 posts)→
More from coding & agent
- Dev launches Jev Search: free open-source tool that picks where to search and ranks results — gaganghotra_ · 2026-09-19
- Ex-Meta Llama 3 RL lead joins Merrai, an AI memory-layer startup, as advisor — misovalko · 2026-09-19
- Braintrust adds Jev as a judge scorer: typed decisions at up to 193.6× speed and 444.6× lower cost — multiply_matrix · 2026-09-19
- Chrome team publishes a framework for designing WebMCP tools for agentic workflows — gaganghotra_ · 2026-09-19
- I spent $3.40 on Jev in 24 hours: it will be Jev + LLMs, not Jev vs LLMs — gaganghotra_ · 2026-09-19
- Agentic Benchmark Checklist paper shows flawed agent benchmarks skew results by up to 100% — ddkang · 2026-09-19